Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Fukuda

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Chemical Communications (Cambridge, England)|August 5, 2021
Acid-mediated intermolecular C-F/C-H cross-coupling of 2-fluorobenzofurans with arenes: synthesis of 2-arylbenzofuransTakeshi Fujita, Ryutaro Morioka, Takuya Fukuda, et al.
Tissue Engineering. Part A|October 4, 2018
Preparation of Immunotolerant Space Under the Skin and Transplantation of Islets in the SpaceRei Kuwabara, Masahide Hamaguchi, Takuya Fukuda, et al.
Journal of Veterinary Internal Medicine|January 11, 2005
Transcatheter closure of congenital ventricular septal defects in 3 dogs with a detachable coilYoko Fujii, Takuya Fukuda, Noboru Machida, et al.
Journal of Diabetes Investigation|October 30, 2019
Standard medical nutrition therapy of 25 kcal/kg ideal bodyweight/day often does not reach even resting energy expenditure for patients with type 2 diabetesTakuya Fukuda, Muhei Tanaka, Masahiro Yamazaki, et al.
General Thoracic and Cardiovascular Surgery|May 23, 2012
Reconstruction of the right ventricular outflow tract after surgical removal of a cardiac hemangiomaMasakazu Sogawa, Takuya Fukuda, Masao Tayama, et al.
Endocrine|May 17, 2017
Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individualsYoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, et al.
Journal of Clinical Biochemistry and Nutrition|August 6, 2019
The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of <i>foxo1</i>Takuro Okamura, Yoshitaka Hashimoto, Takafumi Osaka, et al.
Medicine|May 5, 2017
Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort studyHashimoto Yoshitaka, Masahide Hamaguchi, Takao Kojima, et al.
Endocrine Journal|July 12, 2016
The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetesYoshitaka Hashimoto, Takafumi Osaka, Takuya Fukuda, et al.
Endocrine|October 2, 2017
Weight gain since age of 20 as risk of metabolic syndrome even in non-overweight individualsYoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Chemical Communications (Cambridge, England)|August 5, 2021
Acid-mediated intermolecular C-F/C-H cross-coupling of 2-fluorobenzofurans with arenes: synthesis of 2-arylbenzofuransTakeshi Fujita, Ryutaro Morioka, Takuya Fukuda, et al.
Tissue Engineering. Part A|October 4, 2018
Preparation of Immunotolerant Space Under the Skin and Transplantation of Islets in the SpaceRei Kuwabara, Masahide Hamaguchi, Takuya Fukuda, et al.
Journal of Veterinary Internal Medicine|January 11, 2005
Transcatheter closure of congenital ventricular septal defects in 3 dogs with a detachable coilYoko Fujii, Takuya Fukuda, Noboru Machida, et al.
Journal of Diabetes Investigation|October 30, 2019
Standard medical nutrition therapy of 25 kcal/kg ideal bodyweight/day often does not reach even resting energy expenditure for patients with type 2 diabetesTakuya Fukuda, Muhei Tanaka, Masahiro Yamazaki, et al.
General Thoracic and Cardiovascular Surgery|May 23, 2012
Reconstruction of the right ventricular outflow tract after surgical removal of a cardiac hemangiomaMasakazu Sogawa, Takuya Fukuda, Masao Tayama, et al.
Endocrine|May 17, 2017
Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individualsYoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, et al.
Journal of Clinical Biochemistry and Nutrition|August 6, 2019
The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of <i>foxo1</i>Takuro Okamura, Yoshitaka Hashimoto, Takafumi Osaka, et al.
Medicine|May 5, 2017
Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort studyHashimoto Yoshitaka, Masahide Hamaguchi, Takao Kojima, et al.
Endocrine Journal|July 12, 2016
The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetesYoshitaka Hashimoto, Takafumi Osaka, Takuya Fukuda, et al.
Endocrine|October 2, 2017
Weight gain since age of 20 as risk of metabolic syndrome even in non-overweight individualsYoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, et al.
Pageof 5